Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous system

被引:34
|
作者
Lee, Tet Woo [1 ,2 ]
Tsang, Vicky W. K. [1 ,2 ]
Birch, Nigel P. [1 ,2 ,3 ]
机构
[1] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand
[2] Univ Auckland, Ctr Brain Res, Auckland 1142, New Zealand
[3] Brain Res New Zealand, Rangahau Roro Aotearoa, Auckland, New Zealand
来源
FRONTIERS IN CELLULAR NEUROSCIENCE | 2015年 / 9卷
关键词
serine protease; serpin; neuronal migration; neurite growth; synaptic plasticity; neurodegeneration and neuroprotection; Alzheimer's disease; neurovascular unit; SERINE-PROTEASE INHIBITOR; LONG-TERM POTENTIATION; BLOOD-BRAIN-BARRIER; PROGRESSIVE MYOCLONUS EPILEPSY; CULTURED HIPPOCAMPAL-NEURONS; ACTIVITY-DEPENDENT RELEASE; RECEPTOR-RELATED PROTEIN; D-ASPARTATE RECEPTORS; MICE LACKING; GENE-EXPRESSION;
D O I
10.3389/fncel.2015.00396
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although its roles in the vascular space are most well-known, tissue plasminogen activator (tPA) is widely expressed in the developing and adult nervous system, where its activity is believed to be regulated by neuroserpin, a predominantly brain-specific member of the serpin family of protease inhibitors. In the normal physiological state, tPA has been shown to play roles in the development and plasticity of the nervous system. Ischemic damage, however, may lead to excess tPA activity in the brain and this is believed to contribute to neurodegeneration. In this article, we briefly review the physiological and pathological roles of tPA in the nervous system, which includes neuronal migration, axonal growth, synaptic plasticity, neuroprotection and neurodegeneration, as well as a contribution to neurological disease. We summarize tPA's multiple mechanisms of action and also highlight the contributions of the inhibitor neuroserpin to these processes.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] TISSUE-PLASMINOGEN ACTIVATOR EXPRESSION IN THE EMBRYONIC NERVOUS-SYSTEM
    FRIEDMAN, GC
    SEEDS, NW
    DEVELOPMENTAL BRAIN RESEARCH, 1994, 81 (01): : 41 - 49
  • [32] Tissue-type plasminogen activator is a neuroprotectant in the central nervous system
    Yepes, Manuel
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2015, 9
  • [33] INHIBITION OF TISSUE PLASMINOGEN-ACTIVATOR ACTIVITY BY ASPIRIN INVIVO AND ITS RELATIONSHIP TO LEVELS OF TISSUE PLASMINOGEN-ACTIVATOR ANTIGEN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND THEIR COMPLEXES
    LEVIN, RI
    HARPEL, PC
    HARPEL, JG
    RECHT, PA
    BLOOD, 1989, 74 (05) : 1635 - 1643
  • [34] FACTORS INFLUENCING THE ANALYSIS OF TISSUE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR
    TAKADA, A
    TAKADA, Y
    HIGHLIGHTS OF MODERN BIOCHEMISTRY, VOLS 1-2, 1989, : 1481 - 1489
  • [35] DETERMINATION OF TISSUE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR IN PLASMA SAMPLES
    CHMIELEWSKA, J
    URDEN, G
    WIMAN, B
    HAEMOSTASIS, 1984, 14 (01) : 100 - 100
  • [36] DETERMINATION OF TISSUE PLASMINOGEN-ACTIVATOR AND ITS FAST INHIBITOR IN PLASMA
    CHMIELEWSKA, J
    WIMAN, B
    CLINICAL CHEMISTRY, 1986, 32 (03) : 482 - 485
  • [37] Roles of tissue plasminogen activator in epidermal stratification
    Lian, XH
    Yang, T
    Xiang, MM
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2003, 27 (2-3) : 231 - 240
  • [38] Tissue plasminogen activator and plasminogen activator inhibitor-1 promote tissue integration of biomaterial
    Hessenauer, M.
    Reichel, C. A.
    Berghaus, A.
    Strieth, S.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 : 8 - 8
  • [39] Role of tissue plasminogen activator and plasminogen activator inhibitor as potential biomarkers in psychosis
    Elmi, Sarah
    Sahu, Geetanjali
    Malavade, Kishor
    Jacob, Theresa
    ASIAN JOURNAL OF PSYCHIATRY, 2019, 43 : 105 - 110
  • [40] Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients
    Lindgren, A
    Lindoff, C
    Norrving, B
    Astedt, B
    Johansson, BB
    STROKE, 1996, 27 (06) : 1066 - 1071